ISB 1442, a first-in-class CD38 and CD47 bispecific antibody innate cell modulator for the treatment of CD38+malignancies
Stefano Sammicheli,Camille Grandclement,Elie Dheilly,Maria Panagopoulou,Evangelia Martini,Perrine Suere,Blandine Pouleau,Carole Estoppey,Julia Frei,Jeremy Loyau,Thierry Monney,Adam Drake,Alain Rubod,Marie Agnes Doucey,Vinu Menon,Venkatesha Udupa,G. N. Sunitha,Daniel Rasmussen,Jeppe Koch Olsen, Roberto Gionannini,Girish Gudi,Ankita Srivastava,Cyril Konto,Mario Perro CANCER RESEARCH（2022）
AI 理解论文
溯源树
样例
